J&J | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Abbott USD 10.36B 610M 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Baxter International USD 2.63B 123M 2025-03
Bayer EUR 13.74B 2.01B 2025-03
Becton, Dickinson and Co. USD 5.27B 102M 2025-03
Biogen USD 2.43B 24.7M 2025-03
Boston Scientific USD 4.66B 99M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
CONMED USD 321.3M 24.64M 2025-03
Cooper Companies USD 964.7M 53.7M 2025-01
Dexcom USD 1.04B 73.5M 2025-03
Edwards Lifesciences USD 1.41B 24.2M 2025-03
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Globus Medical USD 598.1M 59.19M 2025-03
Hologic USD 1.01B 11.8M 2025-03
Indivior 266M 32M 2025-03
Insulet USD 569M 28.5M 2025-03
Integra LifeSciences USD 382.7M 59.95M 2025-03
Intuitive Surgical USD 2.25B 160M 2025-03
J&J USD 21.89B 630M 2025-03
Medtronic USD 8.93B 638M 2025-03
Merck USD 15.53B 94M 2025-03
Merit Medical Systems USD 355.4M 242K 2025-03
Novartis USD 13.15B 330M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Stryker USD 5.9B 536M 2025-03
Tandem Diabetes Care USD 234.4M 48.25M 2025-03
Teva Pharmaceutical Industries USD 14.06B 1.27B 2025-03
Vertex Pharmaceuticals USD 2.77B 142M 2025-03
Zimmer Biomet Holdings USD 1.91B 113.2M 2025-03
Zoetis USD 2.22B 97M 2025-03



J&J Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.